| |
|
|
|
|
|
|
|||
|
Blood, 29 January 2009, Vol. 113, No. 5, pp. 1149-1157. Prepublished online as a Blood First Edition Paper on December 1, 2008; DOI 10.1182/blood-2008-03-144683.
Submitted March 11, 2008
Department of Haematology, Imperial College London, London, United Kingdom * Corresponding author; email: j.crawley{at}imperial.ac.uk.
ADAMTS13 regulates the multimeric size of von Willebrand factor (VWF). Its function is highly dependent upon Ca2+ ions. Using the initial rates of substrate (VWF115, VWF residues 1554-1668) proteolysis by ADAMTS13 pre-incubated with varying Ca2+ concentrations, a high affinity functional ADAMTS13 Ca2+ binding site was suggested with KD(app) of 80 ± 15µM, corroborating a previously reported study. When Glu83 or Asp173 (residues involved in a predicted Ca2+ binding site in the ADAMTS13 metalloprotease domain) were mutated to alanine, Ca2+ dependence of proteolysis of the substrate was unaffected. Consequently, we sought and identified a candidate Ca2+ binding site in close proximity to the ADAMTS13 active site, potentially comprising Glu184, Asp187 and Glu212. Mutagenesis of these residues within this site to alanine dramatically attenuated the KD(app) for Ca2+ of ADAMTS13, and for D187A and E212A also reduced the Vmax to ~25% normal. Kinetic analysis of the Asp187 mutant in the presence of excess Ca2+ revealed a ~13 fold reduction in specificity constant, kcat/Km, contributed by changes in both Km and kcat. These results were corroborated using plasma purified VWF as a substrate. Together, our results demonstrate that a major influence of Ca2+ upon ADAMTS13 function is mediated through binding to a high affinity site adjacent to its active site cleft.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||